Kennebec Savings Bank’s ARK Genomic Revolution ETF ARKG Stock Holding History
Bought
Maintained
Sold
Other funds holding ARKG
Kennebec Savings Bank's ARKG Position: Q4 2025 in Review
Kennebec Savings Bank sold out of ARK Genomic Revolution ETF (ARKG) in Q4 2025, closing a stake of 356 shares — an estimated $9.89K sold.
Kennebec Savings Bank first reported a position in ARKG in Q3 2025 and held it in 1 quarter. The position peaked at $9.89K in Q3 2025. 239 funds tracked by Wall St. Rank hold ARKG as of Q4 2025.
- Kennebec Savings Bank reported no remaining ARK Genomic Revolution ETF position as of Q4 2025 after selling out during the quarter.
- Kennebec Savings Bank sold 356 ARK Genomic Revolution ETF shares in Q4 2025, an estimated $9.89K.
- Kennebec Savings Bank first reported a position in ARK Genomic Revolution ETF in Q3 2025 and held it in 1 quarter.
- Kennebec Savings Bank's ARK Genomic Revolution ETF position peaked at $9.89K in Q3 2025.
- 239 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q4 2025.
Based on Kennebec Savings Bank's 13F filing for Q4 2025, filed 22 Jan 2026.